164 related articles for article (PubMed ID: 30785941)
1. Evaluation of hemostasis in patients with end-stage renal disease.
Gäckler A; Rohn H; Lisman T; Benkö T; Witzke O; Kribben A; Saner FH
PLoS One; 2019; 14(2):e0212237. PubMed ID: 30785941
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Hemostatic Parameters and Platelet Function on Thromboelastometry and Impedance Aggregometry in Hemodialysis Patients Qualified for Kidney Transplantation: Preliminary Report.
Pluta J; Nicińska B; Grzeszczyk M; Kołacz M; Jureczko L; Kwiatkowski A; Durlik M; Trzebicki J
Transplant Proc; 2016 Jun; 48(5):1431-4. PubMed ID: 27496422
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease.
Abdelmaguid A; Roberts LN; Tugores L; Joslin JR; Hunt BJ; Parmar K; Nebres D; Naga SS; Khalil ES; Bramham K
J Thromb Haemost; 2022 Apr; 20(4):845-856. PubMed ID: 35068080
[TBL] [Abstract][Full Text] [Related]
4. Assessment of haemostasis and impact of fibrinogen supplementation on clot properties using global haemostasis assays in patients on chronic dialysis.
Pluta J; Nicińska B; Durlik M; Trzebicki J
Anaesthesiol Intensive Ther; 2020; 52(4):274-280. PubMed ID: 33165877
[TBL] [Abstract][Full Text] [Related]
5. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
6. Effect of hemodialysis on platelet function in end-stage renal disease Egyptian patients using in vitro closure time test (PFA-100 analyzer).
Mekawy MA; Habashy DM; Abd El-Mohsen WA
Platelets; 2015; 26(5):443-7. PubMed ID: 24955720
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis.
Malyszko J; Malyszko JS; Mysliwiec M
Perit Dial Int; 2001; 21(2):158-65. PubMed ID: 11330560
[TBL] [Abstract][Full Text] [Related]
8. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
Salvati F; Liani M
Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical and laboratory parameters in patients with end-stage renal failure in the outcome of chronic glomerulonephritis and patients with end-stage renal failure in the outcome of other diseases.
Popova JA; Yadrihinskaya VN; Krylova MI; Sleptsovа SS; Borisovа NV
Wiad Lek; 2016; 69(6):739-741. PubMed ID: 28214807
[TBL] [Abstract][Full Text] [Related]
10. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
[TBL] [Abstract][Full Text] [Related]
11. [Influence of hemodialysis on expression of glycoprotein lb platelets reactivity in patients with the end stage renal failure].
Brzósko S; Hryszko T; Zak J; Wysocka J; Małyszko J; Myśliwiec M
Przegl Lek; 2002; 59(10):823-5. PubMed ID: 12632921
[TBL] [Abstract][Full Text] [Related]
12. Utility of in vitro closure time test for evaluating platelet-related primary hemostasis in dialysis patients.
Zupan IP; Sabovic M; Salobir B; Ponikvar JB; Cernelc P
Am J Kidney Dis; 2003 Oct; 42(4):746-51. PubMed ID: 14520625
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of abnormal in vitro closure time using the Platelet Function Analyzer-100 in chronic kidney disease patients and analysis of associated factors.
Kim HJ; Kim KM; Koo TY; Chi HS; Kim SH; Kim SB
Clin Nephrol; 2011 Sep; 76(3):195-200. PubMed ID: 21888856
[TBL] [Abstract][Full Text] [Related]
14. Platelet and coagulation function before and after burn and smoke inhalation injury in sheep.
Prat NJ; Herzig MC; Kreyer S; Montgomery RK; Parida BK; Linden K; Scaravilli V; Belenkiy SM; Cancio LC; Batchinsky AI; Cap AP
J Trauma Acute Care Surg; 2017 Jul; 83(1 Suppl 1):S59-S65. PubMed ID: 28452873
[TBL] [Abstract][Full Text] [Related]
15. Hemodialysis shortens long in vitro closure times as measured by the PFA-100.
Bilgin AU; Karadogan I; Artac M; Kizilors A; Bligin R; Undar L
Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
Malyszko J; Suchowierska E; Malyszko JS; Mysliwiec M
Perit Dial Int; 2002; 22(5):582-92. PubMed ID: 12455569
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
Małyszko J; Małyszko JS; Myśliwiec M
Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
[TBL] [Abstract][Full Text] [Related]
18. Platelet function in patients on long term peritoneal dialysis.
Lindsay RM; Friesen M; Koens F; Linton AL; Oreopoulos D; de Veber G
Clin Nephrol; 1976 Aug; 6(2):335-9. PubMed ID: 954241
[TBL] [Abstract][Full Text] [Related]
19. Assessment of hemostatic changes after initiation of continuous venovenous hemodialysis.
Wand S; Schneider S; Meybohm P; Zacharowski K; Weber CF
Clin Lab; 2015; 61(3-4):379-87. PubMed ID: 25975006
[TBL] [Abstract][Full Text] [Related]
20. [Study of changes in hemostasis in patients with chronic renal insufficiency treated with peritoneal dialysis].
Malý J; Kacerovský J; Pecka M; Siroký O; Bláha M; Jebavý L
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):277-93. PubMed ID: 6985167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
